Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
acs can
May 14, 2024, 10:59 |
Blog
Vivek Subbiah: Sharing our editorial on Rationalizing rules for immunotherapy combination trials
Vivek Subbiah shared on X: “Sharing our editorial on rationalizing rules for immunotherapy combination trials,…
May 6, 2024, 08:22 |
Positive
Jill Feldman: We've been talking the talk, but Narjust Florez is walking the walk!
Jill Feldman shared a post by Florez Lab on X: "We've been talking the talk,…
May 3, 2024, 19:20 |
Blog
Aman Chauhan: Its been almost two years in making AJCC staging for NETs
Aman Chauhan, Leader of Neuroendocrine Cancer Program at Sylvester Comprehensive Cancer Center, shared on X/Twitter: "Its…
May 3, 2024, 16:17 |
Blog
Paolo Tarantino: HER2-low: should we even test?
Paolo Tarantino shared a post on X: "The timing couldn’t be more appropriate for this…
May 1, 2024, 08:43 |
Insight
Naveen Pemmaraju: It’s time to talk about revised endpoints for Myelofibrosis clinical trials
Naveen Pemmaraju shared on X/Twitter: "It’s time to talk about revised endpoints for Myelofibrosis clinical…
Apr 30, 2024, 19:30 |
Blog
Nieves Martinez Lago: Critical updates in neuroendocrine tumors
Nieves Martinez Lago, Medical Oncologist at University Hospital Complex of Ferrol, shared on X/Twitter: “Critical…
Apr 26, 2024, 11:05 |
Blog
Paolo Tarantino: Wonderful experience to brainstorm about the agnostic potential of ADCs with Roberto Carmagnani Pestana
Paolo Tarantino, Research Fellow at Dana Farber Cancer Institute, shared a post by Roberto Carmagnani Pestana,…
Apr 22, 2024, 11:52 |
Insight
Kelley C. Wood: What's important to older adults receiving chemotherapy?
Kelley C. Wood, Research Director at ReVital Cancer Rehab, shared a post by Enrique Soto…
Apr 21, 2024, 21:27 |
Drugs
Hagop Kantarjian: We review the evidence leading to Tagraxofusp approval as first in class CD123-directed drug which has changed the field of BPDCN
Hagop Kantarjian, Leukaemia professor and Chair at MD Anderson Cancer Center, shared on X: “Tazgraxofusp is…
Apr 20, 2024, 08:50 |
Blog
Cristiane Bergerot: It's time to integrate evidence-based FCR interventions into existing guidelines to enhance survivorship and alleviate silent suffering
Cristiane Bergerot shared on X/Twitter: "Proud to have collaborated on this document with star colleagues. Daniel…
51
52
53
54
55
All:
575
Posts:
521 - 530
ASTRO24: 15 Posts Not To Miss From Day 4
Top 100 Xfluencers in Prostate Cancer: Key Opinion Leaders to follow on X (Twitter) in 2024
Paper Alert! Cutaneous Metastases in Thyroid Cancer: A Comprehensive Review of 136 Cases
ASTRO 24: 15 Posts Not to Miss From Day 3
Gavin Creel: Broadway Icon Dies After Battle with Rare Sarcoma at 48
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube